Seguir
Rezvan Faisal Abduljabbar
Rezvan Faisal Abduljabbar
Department of Clinical Pharmacy, University of Duhok, Kurdistan Region, Iraq.
Dirección de correo verificada de uod.ac - Página principal
Título
Citado por
Citado por
Año
Prognostic significance of androgen receptor expression in invasive breast cancer: transcriptomic and protein expression analysis
MA Aleskandarany, R Abduljabbar, I Ashankyty, A Elmouna, D Jerjees, ...
Breast cancer research and treatment 159, 215-227, 2016
1042016
Clinical and biological significance of glucocorticoid receptor (GR) expression in breast cancer
R Abduljabbar, OH Negm, CF Lai, DA Jerjees, M Al-Kaabi, MR Hamed, ...
Breast cancer research and treatment 150, 335-346, 2015
952015
Expression of CDK7, cyclin H, and MAT1 is elevated in breast cancer and is prognostic in estrogen receptor–positive breast cancer
H Patel, R Abduljabbar, CF Lai, M Periyasamy, A Harrod, C Gemma, ...
Clinical Cancer Research 22 (23), 5929-5938, 2016
922016
Cancer Incidence Rates in the Kurdistan Region/Iraq from
RT Othman, R Abdulljabar, A Saeed, S Sadiq, HM Kittani, SA Mohammed, ...
Asian Pacific Journal of Cancer Prevention 12 (5), 1261-64, 2011
632011
Prognostic and biological significance of peroxisome proliferator-activated receptor-gamma in luminal breast cancer
R Abduljabbar, MM Al-Kaabi, OH Negm, D Jerjees, AA Muftah, ...
Breast cancer research and treatment 150, 511-522, 2015
342015
ERK1/2 is related to oestrogen receptor and predicts outcome in hormone-treated breast cancer
DA Jerjees, M Alabdullah, M Alkaabi, R Abduljabbar, A Muftah, C Nolan, ...
Breast cancer research and treatment 147, 25-37, 2014
202014
Dyslipidemia in subclinical hypothyroidism: a case-control study
B Qasim, S Arif, A Mohammed, R Abduljabbar
J Endocrinol Diab 5 (1), 1-6, 2018
182018
The mammalian target of rapamycin complex 1 (mTORC1) in breast cancer: the impact of oestrogen receptor and HER2 pathways
DA Jerjees, OH Negm, ML Alabdullah, S Mirza, M Alkaabi, MR Hameed, ...
Breast cancer research and treatment 150, 91-103, 2015
112015
Clinicopathologic significance of androgen receptor expression in invasive breast cancer: A comprehensive analysis in large cohorts
MA Aleskandarany, R Abduljabbar, S Sonbul, CF Lai, S Ali, ...
European Journal of Cancer 1 (61), S207, 2016
12016
Categorization of the Nottingham Prognostic Index in Breast Carcinoma: A Retrospective Study of 473 Female Patients
MR Mohammed, R Abduljabbar, A Raziq, D Musa
Al-Anbar Medical Journal 19 (2), 110-115, 2023
2023
BRCA1/2 Testing and/or Further Genetic Assessment Scoring Sheet: A Useful Clinical Tool
RF Abduljabbar
JOURNAL OF PATHOLOGY 243, S23-S23, 2017
2017
EVALUATION OF SERUM ZINC LEVEL IN LIVER CIRRHOSIS PATIENTS IN DUHOK GOVERNORATE
RF ABDULJABBAR, M HABEEB, A SALIH, BA QASIM
Duhok Medical Journal 10 (1), 2016
2016
Improvement of Ki67 Staining in Breast Cancer (BC)
AA Muftah, M Aleskandarany, MM Al-Kaabi, DA Jerjees, RF Abduljabbar, ...
JOURNAL OF PATHOLOGY 237, S30-S30, 2015
2015
ERK1/2 expression in breast cancer: The impact of subcellular localisation
D Jerjees, O Nejm, S Mirza, R Abduljabbar, N Alsubhi, C Nolan, A Green, ...
VIRCHOWS ARCHIV 465, S107-S107, 2014
2014
Activated c-Jun is a luminal-related marker associated with better outcome in breast cancer
D Jerjees, R Abduljabbar, A Muftah, C Nolan, A Green, I Ellis, E Rakha
VIRCHOWS ARCHIV 465, S93-S93, 2014
2014
Androgen receptor is an independent predictor of outcome in breast cancer that performs better than progesterone receptor
R Abduljabbar, A Green, D Jerjees, C Nolan, L Buluwela, S Ali, I Ellis, ...
VIRCHOWS ARCHIV 465, S97-S97, 2014
2014
p38 MAPK is a marker of good prognosis in breast cancer and is an independent predictor of better outcome in the luminal class
D Jerjees, R Abduljabbar, M AL-Kaabi, C Nolan, A Green, I Ellis, E Rakha
VIRCHOWS ARCHIV 465, S93-S93, 2014
2014
The biological and clinical significance of phosphorylated mTOR (pi3k/AKt pathway related) and its association with estrogen receptor and HER2 pathways
D Jerjees, O Nejm, S Mirza, R Abduljabbar, A Green, P Tighe, V Band, ...
VIRCHOWS ARCHIV 465, S99-S99, 2014
2014
The proliferation marker Ki67 in breast cancer: A reliability study to assess its readiness for routine clinical management
AA Muftah, M Al-Kaabi, M Aleskandarany, D Jerjees, N Alsobhi, ...
VIRCHOWS ARCHIV 465, S104-S104, 2014
2014
Peroxisome proliferator-activated receptor gamma expression is useful predictive and prognostic tool in luminal breast cancer
R Abduljabbar, D Jerjees, A Green, C Nolan, L Buluwela, S Ali, E Rakha, ...
VIRCHOWS ARCHIV 465, S105-S106, 2014
2014
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20